Moderately to Severely Active Crohn Disease

Immunology·MeSH: Crohn Disease

5 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 2(5)

Drug	Company
obefazimod	Abivax SA (ABVX)
Obefazimod	Abivax SA (ABVX)
Obefazimod 50 mg Capsule	Abivax SA (ABVX)
obefazimod mini	Abivax SA (ABVX)
obefazimod mini	Abivax SA (ABVX)

Compare drugs

obefazimod vs Obefazimod 50 mg Capsule obefazimod vs obefazimod mini

Frequently asked questions

How many drugs are in development for Moderately to Severely Active Crohn Disease?

BioSniper tracks 5 drugs in development for Moderately to Severely Active Crohn Disease across 1 company.

How many clinical trials target Moderately to Severely Active Crohn Disease?

There are 1 clinical trial targeting Moderately to Severely Active Crohn Disease tracked by BioSniper.

Deep-dive into Moderately to Severely Active Crohn Disease

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Moderately to Severely Active Crohn Disease — Drugs in Development & Clinical Trials | BioSniper